Wegovy costs $1,349 a month versus $1,086 for Zepbound for a 28-day supply
This pill comes after years of demand for an oral version of the previously injectable-only treatment, and three months after Novo Nordisk beat Lilly to the punch and launched oral Wegovy, the first FDA-approved oral GLP-1, with a self-pay price also starting at $149 a month through August 31
To view or add a comment, sign in A recent finding from Duke University School of Medicine is changing our understanding of blood sugar control
Highly promising results have been achieved using new agents dedicated to this group of patients, including lomitapide (Lojuxta) [289] available in doses from 5 to 60 mg, mipomersen (Kynamro, which was not authorised for use by the EMA in 2013), as well as new therapies, including, above all, evinacumab (Evkeeza) (Section 9.10), which since June 2021, following a positive decision of the EMA, have been authorised for use in patients with HoFH in the European Union